Search results for "HYPERTENSION"

showing 10 items of 1283 documents

Hiatal herniation of the stomach and pancreas in a patient with oxygen desaturations

2013

Hiatal hernia (HH), a neglected cause of cardiorespiratory symptoms, is a frequent entity characterized by the displacement of the gastro- esophageal junction and part of the stomach into the mediastinum. Although often asymptomatic, HH may also exert a wide spectrum of clinical presentations due to cardio-pulmonary compression, including acute cardiovascular events such as arrhythmias, post-prandial syncope, angina-like chest pain, recurrent acute heart failure, hemodynamic collapse, electrocardiographic changes (T-wave inversion, ST elevation) simulating myocardial ischemia or pericarditis, and respiratory manifestations that can range from exercise intolerance and dyspnea on exertion to …

medicine.medical_specialtybusiness.industryST elevationGeneral MedicineExercise intolerancemedicine.diseaseChest painAsymptomaticPulmonary function testingHiatal hernia ;respiratory desaturation ; pancreas; pulmonary hypertensionHiatal herniaPericarditisHeart failureInternal medicineCardiologyMedicineMedicinecardiovascular diseasesmedicine.symptombusinessLetter to the EditorThe Libyan Journal of Medicine
researchProduct

Different Morning Blood Pressure Increases are Associated to a Diverse Microvascular Damage

2007

medicine.medical_specialtybusiness.industryStiffness indexRenal functionEssential hypertensionmedicine.diseasemedicine.anatomical_structurePharmacotherapyInternal medicineAmbulatoryInternal MedicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessArteryHigh Blood Pressure & Cardiovascular Prevention
researchProduct

The Prognostic Role of Hypertrabeculation By Cardiac Magnetic Resonance in Thalassemia Intermedia Patients

2016

Abstract Background. Differentiation of left ventricle non-compaction (LVNC) from hypertrabeculated LV due to a negative heart remodeling in thalassemia intermedia (TI) can depends on the selected CMR criterion. The recently proposed Piga's criterion (NC/C ratio threshold of >2.5, Am J Haem 2012) seems to have a low specificity to identify the true LVNC in TI. Anyway, the Piga's criterion could well detect easy a negative heart remodeling in TI patients. Purpose: To assess prospectively whether the Piga's criterion has a prognostic role for adverse cardiovascular outcomes in TI patients. Methods. We studied prospectively by CMR 168 TI patients (81 males, mean age 38.32 ±11.61 years) cons…

medicine.medical_specialtybusiness.industryThalassemiaImmunologyCardiac arrhythmiaCell BiologyHematology030204 cardiovascular system & hematologymedicine.diseaseBiochemistryPulmonary hypertensionSurgery03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureVentricleHeart failureInternal medicinemedicineCardiologyPopulation study030212 general & internal medicineThalassemia intermediabusinessCardiac magnetic resonanceBlood
researchProduct

Chronische thromboembolische pulmonale Hypertonie: Hämodynamische Auswirkungen der selektiven Pulmonalis-DSA mit nicht-ionischem Kontrastmittel

1998

PURPOSE This study evaluates the effects of pulmonary bolus injection of nonionic contrast medium on pulmonary artery pressure and resistance in patients with chronic thromboembolic pulmonary hypertension. METHODS In 39 patients (age 52 +/- 15) haemodynamic measurements were performed during bolus injection of nonionic contrast medium in a control group (I), in moderately severe (II) and severe pulmonary hypertension (III). RESULTS Initial inspiratory arrest caused significant pressure increase in all groups prior to bolus injection (delta PAsyst: 7.1 +/- 6.7 [I], 6.8 +/- 3.9 [II] und 7.2 +/- 7.9 mmHg p < 0.05). However, contrast bolus injection (25.1 +/- 2.3 ml iopamidol, 13.0 ml/s) caused…

medicine.medical_specialtybusiness.industryVascular diseaseRespiratory diseaseHemodynamicsmedicine.diseasePulmonary hypertensionIopamidolSurgeryContrast mediummedicine.anatomical_structureInternal medicinemedicine.arteryPulmonary arterymedicineCardiologyVascular resistanceRadiology Nuclear Medicine and imagingbusinessmedicine.drugRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Effects of Tolazoline and Prostacyclin on Pulmonary Hypertension in Infants After Cardiac Surgery

1992

Objective To evaluate the hemodynamic effects of tolazoline and prostacyclin in infants with pulmonary vasospasm after cardiac surgery. Design Prospective cohort study. Setting Pediatric ICU. Patients The cohort consisted of 42 infants and children with congenital heart disease and pulmonary hypertension who underwent corrective surgery and were monitored postoperatively using pulmonary artery catheters. Fourteen infants (2 to 12 months old) in this group required postoperative treatment with tolazoline or prostacyclin. Interventions Tolazoline was administered as a bolus of 0.5 mg/kg for treatment of persistent pulmonary hypertension or acute pulmonary hypertensive crisis. If its effective…

medicine.medical_specialtybusiness.industryVasospasmProstacyclinCritical Care and Intensive Care Medicinemedicine.diseasePulmonary hypertensionCardiac surgerymedicine.anatomical_structureBolus (medicine)medicine.arteryAnesthesiaInternal medicinePulmonary arteryVascular resistancemedicineCardiologyTolazolinebusinessmedicine.drugSurvey of Anesthesiology
researchProduct

Hemodynamic Changes in Patients with Essential Hypertension after Therapy with Muzolimine

1987

Muzolimine is a new nonsulfonamide diuretic belonging to the pyrazolinone group (1).It is a potent high-ceiling diuretic agent like furosemide and bumetanide with long duration of action like thiazides (1, 2).

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCardiac indexFurosemideHemodynamicsEssential hypertensionmedicine.diseasechemistry.chemical_compoundchemistryInternal medicinemedicineCardiologyMuzolimineIn patientDiureticbusinessBumetanidemedicine.drug
researchProduct

Chronisch thromboembolische pulmonale Hypertonie: Empfehlungen der Kölner Konsensus Konferenz 2016

2016

The 2015 European Guidelines on Pulmonary Hypertension did not cover only pulmonary arterial hypertension (PAH), but also other significant subgroups of pulmonary hypertension (PH). In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany to discuss open and controversial issues surrounding the practical implementation of the European Guidelines. Several working groups were initiated, one of which was dedicated to the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). In ev…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentConsensus conference610 Medicine & health2700 General MedicineGeneral Medicine030204 cardiovascular system & hematologymedicine.diseasePulmonary hypertension3. Good healthPulmonary endarterectomy03 medical and health sciences0302 clinical medicinePharmacotherapy030228 respiratory systemAngioplastymedicine.arteryPulmonary arterymedicineChronic thromboembolic pulmonary hypertension10178 Clinic for PneumologyIntensive care medicinebusinessPediatric cardiologyDMW - Deutsche Medizinische Wochenschrift
researchProduct

Orthostatism modifies insulin-like growth factor 1 and insulin plasma levels in essential hypertension.

1999

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentInsulinPlasma levelsmedicine.diseaseEssential hypertensionInsulin-like growth factorEndocrinologyInternal medicinePathophysiology of hypertensionInternal MedicinemedicinebusinessAmerican Journal of Hypertension
researchProduct

COSMIC project : consensus on the objectives of the metabolic syndrome in clinic

2018

Juan Pedro-Botet,1 Juan F Ascaso,2,3 Vivencio Barrios,4,5 Alejandro De la Sierra,6 Javier Escalada,7,8 Jes&uacute;s Mill&aacute;n,9 Jose M Mostaza,10 Pablo P&eacute;rez-Mart&iacute;nez,8,11 Xavier Pint&oacute;,8,12 Jordi Salas-Salvad&oacute;,8,13 Pedro Valdivielso14 1Lipids and Vascular Risk Unit, Hospital del Mar, Universitat Aut&ograve;noma de Barcelona, Barcelona, Spain; 2Endocrinology and Nutrition Service, Hospital Cl&iacute;nico, Universitat de Valencia, Valencia, Spain; 3INCLIVA Research Institute, Diabetes and Metabolic Diseases Ciber (Networked Biomedical Research Centres &ndash; CIBERDEM), Carlos III, Valencia, Spain; 4Cardiology Service, Hospital Universitario Ram&oacute;n y Caja…

medicine.medical_specialtydiabetes preventionSpecialties of internal medicineReviewDiseaseType 2 diabetes030204 cardiovascular system & hematologymetabolic syndromeScientific evidence03 medical and health sciences0302 clinical medicineDiabetes mellitusinsulin resistanceInternal MedicinemedicineCor -- Malalties -- Prevenció030212 general & internal medicineObesityRisk factorDiabetes preventionIntensive care medicineAbdominal obesityobesity.Pharmacologybusiness.industrycardiovascular preventionInsulin resistancemedicine.diseaseDiabetis -- PrevencióCardiovascular preventionRC581-951DyslipidemiaHypertensionObesitatHipertensióMetabolic syndromemedicine.symptombusinessDyslipidemia
researchProduct

Treatment of patients with essential hypertension and microalbuminuria.

1998

There has been increasing interest in the question of whether microalbuminuria can be used in the risk stratification of patients with essential hypertension. A cluster of cardiovascular and/or renal risk factors may be associated with microalbuminuria in hypertension. Despite this, prospective data about the potential role of microalbuminuria as a prognostic marker of cardiovascular and/or renal risk have been sparse and inconclusive until now. Blood pressure values have been considered the most important determinant of microalbuminuria in essential hypertension; however, hyperinsulinaemia--a metabolic component-was noted to be present in conjunction with high blood pressure. Furthermore, …

medicine.medical_specialtyendocrine system diseasesbusiness.industrynutritional and metabolic diseasesProspective dataurologic and male genital diseasesmedicine.diseaseDisease clusterEssential hypertensionfemale genital diseases and pregnancy complicationsSurgeryPharmacotherapyFelodipineInternal medicineRisk stratificationHypertensionmedicineDoxazosinAlbuminuriaHumansPharmacology (medical)MicroalbuminuriabusinessAntihypertensive Agentsmedicine.drugDrugs
researchProduct